4//SEC Filing
KAPLAN GILLA 4
Accession 0000950170-25-086960
CIK 0001863127other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:05 PM ET
Size
8.6 KB
Accession
0000950170-25-086960
Insider Transaction Report
Form 4
KAPLAN GILLA
Director
Transactions
- Sale
Common Stock
2025-06-12$10.31/sh−30,000$309,255→ 59,623 total - Sale
Common Stock
2025-06-16$10.38/sh−6,814$70,726→ 37,809 total - Sale
Common Stock
2025-06-13$10.31/sh−15,000$154,583→ 44,623 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.35 to $10.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001247024
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:05 PM ET
- Size
- 8.6 KB